Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson beats in Q2; raises FY guidance

Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2 sales of $23.3 billion, up 27% year-over-year and higher than the Wall Street projection. Net income of $2.48 per share was also above the target that analysts had anticipated.

JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.

 johnson & Johnson Q2 2021 earnings

Looking forward to listening to management/analyst comments on the results? Stay tuned here for Johnson & Johnson Q2 earnings call transcript

Prior performance

  • Johnson & Johnson Q4 2020 earnings
  • Johnson & Johnson Q3 2020 earnings
  • Johnson and Johnson reports Q2 2020 earnings results

Most Popular

Digital wine club Winc gears up for $80-mln IPO. Here’s all you need to know

The virus-driven shift in consumer behavior has made businesses revisit their strategies, and the alcohol industry is no exception. While the IPO frenzy continues unabated, led by the technology and

IPO news: What to look for when Portillo’s Inc. makes its market debut next week

The food industry is witnessing a rebound as people revert to their earlier habits of eating out. Street food has always been popular among those who are looking for a

Charles Schwab Corp. (SCHW) Q3 earnings beat estimates amid 87% revenue growth

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Friday reported strong revenue and earnings growth for the third quarter. The numbers also beat Wall Street's forecast. Third-quarter revenues

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top